Krystal Biotech Cash from Operations (TTM) Analysis

Krystal Biotech Inc (KRYS)

163.99 +0.21 (+0.13%) USD | NASDAQ | May 17, 16:00

163.99 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	-46.76M
December 31, 2023	-88.80M
September 30, 2023	-103.90M
June 30, 2023	-102.36M
March 31, 2023	-111.23M
December 31, 2022	-100.57M
September 30, 2022	-99.14M
June 30, 2022	-86.71M
March 31, 2022	-53.78M
December 31, 2021	-47.94M
September 30, 2021	-35.06M
June 30, 2021	-34.58M
March 31, 2021	-29.51M

Date	Value
December 31, 2020	-26.08M
September 30, 2020	-25.06M
June 30, 2020	-22.55M
March 31, 2020	-21.70M
December 31, 2019	-18.69M
September 30, 2019	-15.21M
June 30, 2019	-12.88M
March 31, 2019	-10.29M
December 31, 2018	-9.445M
September 30, 2018	-8.054M
June 30, 2018	-7.212M
March 31, 2018	-6.002M
December 31, 2017	-3.89M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-111.23M

Minimum

Mar 2023

-12.88M

Maximum

Jun 2019

-54.13M

Average

-40.91M

Median

Cash from Operations (TTM) Benchmarks